Virolens Advantages

From the lab to the field for immediate diagnostics and mass screening at the point-of-care.

A NEW APPLICATION OF EXISTING TECHNOLOGIES

Virolens is a new, rapid screening device that combines microscopic holographic imaging and artificial intelligence (AI) software technology.

FAST AND EASY

The system does not require a trained biologist to determine the results. It takes approximately 20 seconds to get a clear positive or negative.

ACCURATE

Virolens has a 98.1% sensitivity and 99.7% specificity. Unlike other tests, Virolens only wants the right answer, not any answer, meaning you can trust the results.

SCALABLE

Virolens does not rely on chemicals or laboratories that are always in short supply, especially during waves of infection. Instead, we start with volumes then work backwards to determine how many machines are needed. Generally, one machine can handle 120 tests per hour with two operators to maximise output.

SAFE

The samples from the screening process are contained inside the collection bin. If sealed in the cartridge, all virus are dead within 72 hours.

ABLE TO COLLECT ANONYMISED DATA

The system collects anonymised data which can be interrogated to understand the spread of SARS-CoV-2 (COVID-19). In simple terms, Virolens machines are geo-tagged and can be used to identify hot spots of infection, further helping to stop the spread of COVID.

FUTURE PROOF SOFTWARE

The system can detect virus patterns as they evolve and change, meaning it will remain effective. In the case of COVID, that means Delta, Omicron and whatever comes next will be unable to hide. The AI technology deployed in the Virolens system can be trained to detect virus patterns as they evolve and change, including the detection of other diseases. iAbra maintains close monitoring of SARS-CoV-2 variants and software updates are provided as needed

APPLICATION TO OTHER DISEASES

Currently the system is trained to look for and recognise COVID-19 but we are working to include other enveloped viruses and respiratory diseases using the same AI technology.


UNDERSTANDING THE TERMS:

Sensitivity is the ability of a test to correctly identify someone with a disease. Specificity is the ability of a test to correctly identify someone without a disease. False positives relate to specificity and false negatives relate to sensitivity.

Virolens detects COVID today; tomorrow it detects all enveloped viruses and respiratory disease.